[ad_1]
In India, the first Zika outbreak was reported in Ahmedabad in January 2017.
The Indian Council for Medical Research (ICMR) will soon undertake trials of the locally developed vaccine against Zika virus, cases of which have been reported in Madhya Pradesh, Rajasthan and Gujarat.
CIMR will begin a phase II trial of the vaccine to determine its efficacy, safety and side effects, a senior official said.
The vaccine manufacturer, Bharat Biotech, based in Hyderabad, has developed a vaccine that they say will provide protection against infections caused by a strain of Asian Zika virus as well as the African strain, he added. .
"The company had developed the vaccine about two years ago, at which time the Zika virus did not break out in India because it was limited to Latin America.
The regulatory approval process for the test will be launched soon, he said.
Two HIV-positive people for the Zika virus died in Bhopal. A total of 120 cases were reported in that State.
A central team is reviewing the situation and helping the government of Madhya Pradesh to replicate the measures and plan of action implemented in Jaipur and Ahmedabad to contain the disease, said the senior official. Rajasthan reported 159 cases of Zika.
In India, the first Zika outbreak was reported in Ahmedabad in January 2017 and the second in Krishnagiri district, Tamil Nadu, in July of the same year. Both epidemics were controlled through intensive surveillance and vector management.
In the last outbreak of the virus in the country, the first case surfaced on September 22, when an 85-year-old woman was tested positive for the virus in Jaipur. Since then, the number of Zika cases has increased to 153 in Rajasthan.
In Madhya Pradesh, an intensive screening exercise is underway and vector control measures have been intensified. The government has also issued a notice to district administrations to take steps to control mosquito breeding.
The state health department advised pregnant women not to visit the affected areas.
[ad_2]
Source link
